Re: Overdiagnosis of bone fragility in the quest to prevent hip fracture
The International Society for Clinical Densitometry (ISCD) is a multidisciplinary, nonprofit organization whose mission is to advance excellence in the assessment of skeletal health. The ISCD wishes to support the comments from the National Bone Health Alliance (NBHA), International Osteoporosis Foundation (IOF), American Society for Bone Mineral Research (ASBMR) and others who have objected to the tone and content of the article. In their provocative article, Teppo Järvinen and colleagues have distorted and misrepresented the osteoporosis burden. The following simple statements of fact are supported by high-level scientific evidence and commonsense:
• Osteoporosis is a disease with major health consequences that include death,
• Osteoporosis remains severely underdiagnosed and undertreated,
• DXA and FRAX are able to identify those at high fracture risk,
• Approved treatments for osteoporosis are effective, safe and additive to non-pharmacological interventions (diet, exercise and fall prevention).
William D. Leslie, MD, MSc, FRCPC, CCD
Competing interests: Speaker fees and/or research grants (all paid to facility): Amgen, Eli Lilly, Novartis, Genzyme.